Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Completed 2Active not recruiting 2Withdrawn 1Unknown 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Neoplasms 4Ovarian Neoplasms 2Motor Activity 2Fallopian Tube Neoplasms 2Uncertainty 1Polyps 1Pancreatic Neoplasms 1Palliative Care 1Pain 1Obesity 1Neoplasm Metastasis 1Lung Neoplasms 1Knee Tumor 1Inflammation 1Head and Neck Neoplasms 1Depression 1Critical Illness 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1Breast Carcinoma In Situ 1Breast Cancer Lymphedema 1Adenoma 1

Interventions

Gemcitabine 77Fluorouracil 27Oxaliplatin 23130-nm albumin-bound paclitaxel 23Leucovorin 17Capecitabine 15Albumin-Bound Paclitaxel 15S 1 (combination) 14Taxes 11Irinotecan 10pembrolizumab 9folfirinox 9Radiosurgery 9Radiotherapy 7Drug Therapy 7irinotecan sucrosofate 6Cisplatin 6Pancreaticoduodenectomy 5Paclitaxel 5Injections 5Docetaxel 5Blood Specimen Collection 5apatinib 4Radiofrequency Ablation 4Radiation 4Biopsy 4tislelizumab 3rubitecan 3camrelizumab 3Stents 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pancreatic Neoplasms × Methods × Clear all
NCT01219192 2010-10-28

Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure

Protgen Ltd

Phase 1 Unknown
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡